Breaking News

WuXi Biologics Expands U.S. Footprint

Closes land deal to build 107,000-sq.-ft., state-of-the-art biologics production facility in Worcester, MA.

By: Contract Pharma

Contract Pharma Staff

WuXi Biologics and the Worcester Business Development Corporation (WBDC) have signed a land deal for WuXi Biologics’ clinical and commercial manufacturing facility in Worcester at The Reactory, a 46-acre master-planned biomanufacturing campus. The approximately 107,000-square-foot, two-story facility will be operational in 2022 and create 150 new jobs.            “As the central Massachusetts biotech community continues its growth, WuXi Biologics’ arrival in Worcester will strengthen the secto...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters